Disease | cardiogenic shock |
Comorbidity | |myocardial infarction |
Sentences | 146 |
PubMedID- 22378251 | Short- and long-term major adverse cardiac events in patients undergoing percutaneous coronary intervention with stenting for acute myocardial infarction complicated by cardiogenic shock. |
PubMedID- 20800217 | After an intake of 40 tablets, he presented a cardiogenic shock with a myocardial infarction confirmed by biological samples, ekg, echocardiography and angiocoronarographie. |
PubMedID- 25812932 | Intra-aortic balloon pump counterpulsation (iabp) for myocardial infarction complicated by cardiogenic shock. |
PubMedID- 22864324 | [acute anterior myocardial infarction presented with cardiogenic shock in a patient on herbal medication]. |
PubMedID- 24656925 | Conclusions: myocardial infarction complicated with cardiogenic shock in elderly patients is an entity with high mortality during hospitalization and continues to worsen during long term follow-up. |
PubMedID- PMC2934137 | In myocardial infarction complicated by cardiogenic shock, levels of bnp and nt-probnp both provide valuable additional information. |
PubMedID- 22572491 | Background: mortality in acute myocardial infarction (ami) complicated by cardiogenic shock (cs) approaches 70 - 80%, regardless of the type of pharmacological treatment. |
PubMedID- 23905448 | Primary percutaneous coronary intervention for st elevation myocardial infarction complicated by cardiogenic shock. |
PubMedID- 23918078 | Sixty-six months later, he had an acute myocardial infarction with cardiogenic shock due to simultaneous 3-vessel very late stent thrombosis (vlst). |
PubMedID- 20346312 | Despite early revascularization, mortality remains high in patients with st-segment elevation myocardial infarction (stemi) complicated by cardiogenic shock. |
PubMedID- 21526919 | Background: the outcome of acute myocardial infarction (ami) complicated with cardiogenic shock is poor. |
PubMedID- 22019211 | Left main coronary artery transradial rescue percutaneous coronary intervention for acute myocardial infarction complicated by cardiogenic shock with impella ventricular mechanical support. |
PubMedID- 25912694 | Effect of abciximab therapy in patients undergoing coronary angioplasty for acute st-elevation myocardial infarction complicated by cardiogenic shock. |
PubMedID- 22212516 | Interleukin-6, -7, -8 and -10 predict outcome in acute myocardial infarction complicated by cardiogenic shock. |
PubMedID- 22126854 | The presence of st-elevation in lead avr predicts significant left main coronary artery stenosis in cardiogenic shock resulting from myocardial infarction: the manitoba cardiogenic shock registry. |
PubMedID- 26148217 | Acute myocardial infarction complicated by cardiogenic shock: an algorithm-based extracorporeal membrane oxygenation program can improve clinical outcomes. |
PubMedID- 24610504 | Background: the influence of age on clinical results of primary percutaneous coronary intervention (pci) in patients with st-elevation myocardial infarctions (stemi) complicated by cardiogenic shock (cs) is poorly investigated. |
PubMedID- 24748798 | This case is an example of a patient who had an in-hospital cardiac arrest due to acute myocardial infarction, complicated by cardiogenic shock. |
PubMedID- 24791717 | Background: data are limited regarding the clinical results of transradial coronary intervention (tri) in acute myocardial infarction (ami) complicated by cardiogenic shock. |
PubMedID- 23312972 | Peripheral venoarterial extracorporeal membrane oxygenation improves survival in myocardial infarction with cardiogenic shock. |
PubMedID- 24657381 | In clinical routine, iabp is mainly used in high-risk patients with acute myocardial infarction, especially when complicated by cardiogenic shock. |
PubMedID- 21849830 | myocardial infarction complicated by cardiogenic shock: a possible role for the impella device. |
PubMedID- 21602670 | Methods: from january 2004 through august 2010, a total of 34 st-elevation myocardial infarction patients with profound cardiogenic shock were admitted to our intensive care unit and treated with either the impella 2.5 or the impella 5.0 device. |
PubMedID- 21944148 | It may be especially useful in patients with acute myocardial infarction complicated by cardiogenic shock who achieve intermacs profile 3 with initial treatment. |
PubMedID- 25654141 | Removed: "erratum to: intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial". |
PubMedID- 21285933 | Early revascularization is the cornerstone treatment of acute myocardial infarction complicated by cardiogenic shock. |
PubMedID- 23264238 | The influence of diabetes on in-hospital and long-term mortality in patients with myocardial infarction complicated by cardiogenic shock: results from the pl-acs registry. |
PubMedID- 25489303 | Introduction: a large, randomised trial (iabp-shock ii) confirmed no benefit of intra-aortic balloon pump (iabp) on clinical outcomes of patients with st-segment elevation myocardial infarction (stemi) complicated by cardiogenic shock. |
PubMedID- 22299378 | We present a case of acute myocardial infarction complicated with cardiogenic shock that underwent primary percutaneous coronary intervention and also review the incidence, pathophysiology, management and outcome of cardiogenic shock complicating acute myocardial infarction. |
PubMedID- 24329756 | The current use of impella 2.5 in acute myocardial infarction complicated by cardiogenic shock: results from the uspella registry. |
PubMedID- 20686421 | Objective: to assess the predictive value of three biomarkers for mortality in st-segment elevation myocardial infarction (stemi) with cardiogenic shock. |
PubMedID- 21385075 | He died of a sudden myocardial infarction with cardiogenic shock 28 months after starting the combination of tkis. |
PubMedID- 23179136 | Intra-aortic balloon pump in patients with acute myocardial infarction complicated by cardiogenic shock: results of the alkk-pci registry. |
PubMedID- 23508129 | Background and objectives: the benefit of early statin treatment following acute myocardial infarction (mi) complicated with cardiogenic shock (cs) has not been well studied. |
PubMedID- 21779281 | St elevation myocardial infarction with cardiogenic shock was more prevalent in the non-survivors than in the survivors (75% vs. |
PubMedID- 22671583 | Little is known about the antiplatelet action of the thienopyridines, clopidogrel and prasugrel, as well as the non-thienopyridine, ticagrelor, in patients suffering from st-elevation myocardial infarction (stemi) complicated by cardiogenic shock since systematic comparisons of these antiplatelet agents in this devastating condition are limited so far. |
PubMedID- 24876220 | cardiogenic shock associated with significant myocardial infarction during the early postoperative period is rare. |
PubMedID- 21055135 | [predictors of short term mortality in patients with acute st-elevation myocardial infarction complicated by cardiogenic shock]. |
PubMedID- 25822657 | Importance: intra-aortic balloon pump (iabp) therapy is a widely used intervention for acute myocardial infarction with cardiogenic shock. |
PubMedID- 24170231 | Background: recent evidence questions the role of intra-aortic balloon counterpulsation (iabp) in the treatment of acute myocardial infarction (ami) complicated by cardiogenic shock (cs). |
PubMedID- 24512409 | Rituximab-vincristine chemotherapy-induced acute anterior wall myocardial infarction with cardiogenic shock. |
PubMedID- 25689547 | Objectives: to investigate the outcome of patients with acute myocardial infarction (ami) complicated by refractory cardiogenic shock (cs) who underwent mechanical circulatory support with impella 2.5. |
PubMedID- 21130711 | Although the use of percutaneous circulatory assist devices is gaining increasing acceptance as an adjunct to percutaneous coronary intervention (pci) in patients with cardiogenic shock, their role in patients with acute myocardial infarction (mi) without hemodynamic compromise and elective high-risk pci remains controversial. |
PubMedID- 20648428 | Blood glucose level on admission determines in-hospital and long-term mortality in patients with st-segment elevation myocardial infarction complicated by cardiogenic shock treated with percutaneous coronary intervention. |
PubMedID- 21339892 | His past medical history included extensive anterior wall myocardial infarction with cardiogenic shock 14 years ago, diabetes mellitus and hypertension. |
PubMedID- 24105454 | Objectives: we investigated the clinical impact of multivessel percutaneous coronary intervention in st-segment elevation myocardial infarction complicated by cardiogenic shock with multivessel disease. |
PubMedID- 22001778 | We report a case of eosinophilic myocarditis manifesting as st-elevation myocardial infarction (stemi) with cardiogenic shock treated successfully with steroids. |
PubMedID- 24380840 | In clinical routine, iabp is mainly used in high-risk patients with acute myocardial infarction, especially when complicated by cardiogenic shock. |
PubMedID- 25885579 | The data on the use of iabp in patients post myocardial infarction with cardiogenic shock remains inconclusive. |
PubMedID- 25819870 | Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock: design and rationale of the intraaortic balloon pump in cardiogenic shock ii (iabp-shock ii) trial. |